Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Shares Outstanding (Diluted Average) (2020 - 2024)

TransMedics (TMDX) has 5 years of Shares Outstanding (Diluted Average) data on record, last reported at $35.7 million in Q3 2024.

  • For Q3 2024, Shares Outstanding (Diluted Average) rose 9.88% year-over-year to $35.7 million; the TTM value through Sep 2024 reached $35.7 million, up 9.88%, while the annual FY2023 figure was $32.5 million, 10.02% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $35.7 million in Q3 2024 per TMDX's latest filing, up from $35.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $35.7 million in Q3 2024 and bottomed at $21.2 million in Q1 2020.
  • Average Shares Outstanding (Diluted Average) over 5 years is $29.4 million, with a median of $28.0 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding (Diluted Average): increased 28.96% in 2021, then increased 1.31% in 2022.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $24.7 million in 2020, then rose by 11.8% to $27.6 million in 2021, then grew by 7.02% to $29.6 million in 2022, then increased by 10.02% to $32.5 million in 2023, then increased by 9.74% to $35.7 million in 2024.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $35.7 million in Q3 2024, $35.3 million in Q2 2024, and $34.7 million in Q1 2024.